H. Fedor

发表

Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy

B. Trock, A. Partin, Misop Han, 2016, PloS one.

Trefoil factor 3 overexpression in prostatic carcinoma: Prognostic importance using tissue microarrays

Jun Luo, A. Partin, P. Walsh, 2004, The Prostate.

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

W. Isaacs, Jun Luo, A. D. De Marzo, 2014, The New England journal of medicine.

Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate Cancer.

B. Trock, H. Scher, L. True, 2018, Archives of pathology & laboratory medicine.

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.

B. Trock, A. Partin, L. Marchionni, 2016, European urology.

SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort.

B. Trock, A. Partin, Misop Han, 2016, The Journal of urology.

A Double-Blind, Randomized, Neoadjuvant Study of the Tissue Effects of POMx Pills in Men with Prostate Cancer Before Radical Prostatectomy

A. Partin, A. Pantuck, S. Freedland, 2013, Cancer Prevention Research.

Variation in IL10 and Other Genes Involved in the Immune Response and in Oxidation and Prostate Cancer Recurrence

Cabral A. Bigman-Galimore, Jianfeng Xu, S. Zheng, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Spatial transcriptomics of FFPE pancreatic intraepithelial neoplasias reveals cellular and molecular alterations of progression to pancreatic ductal carcinoma

L. Wood, E. Jaffee, E. Fertig, 2022, bioRxiv.

1543: The Prevalence and Extent of Autopsy Benign Prostatic Hyperplasia (BPH) is Less in South East Asian Men than North American Men

E. Platz, A. Marzo, C. Magi-Galluzzi, 2004 .

PanIN and CAF Transitions in Pancreatic Carcinogenesis Revealed with Spatial Data Integration

L. Wood, E. Jaffee, H. Fedor, 2022 .

In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading

J. Hicks, E. Platz, Misop Han, 2016, Virchows Archiv.

loss chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active

B. Trock, H. Fedor, H. Carter, 2016 .

Re: Decision Making in Prostate Cancer Screening Using Decision Aids vs Usual Care: A Randomized Clinical Trial

W. Isaacs, M. Halushka, J. Hicks, 2014 .

798OAR-V7 SPLICE VARIANT AND RESISTANCE TO ENZALUTAMIDE AND ABIRATERONE IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): OVERALL SURVIVAL RESULTS

W. Isaacs, A. Marzo, H. Fedor, 2014 .

Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers

S. Isaacs, W. Isaacs, C. Ewing, 2017, Oncotarget.

Practical methods for tissue microarray construction.

A. D. De Marzo, H. Fedor, Helen L. Fedor, 2005, Methods in molecular medicine.

Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion

J. Hicks, H. Fedor, T. Lotan, 2013, Prostate Cancer and Prostatic Diseases.

A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer

P. Febbo, A. Jimeno, A. Partin, 2010, Clinical Cancer Research.

Individual and cumulative effect of prostate cancer risk‐associated variants on clinicopathologic variables in 5,895 prostate cancer patients

B. Trock, Jianfeng Xu, Jielin Sun, 2009, The Prostate.

A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms

W. Isaacs, J. Sauvageot, A. D. De Marzo, 2008, The Prostate.

Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data.

Jun Luo, T. Dunn, A. D. De Marzo, 2012, Asian journal of andrology.

Preferential 8q24 Allelic Imbalance and MYC gene Copy Number in Primary Prostate Cancer

R. Kittles, W. Isaacs, H. Fedor, 2010, Prostate Cancer and Prostatic Diseases.

Tracking the clonal origin of lethal prostate cancer.

W. Isaacs, M. Halushka, J. Hicks, 2013, The Journal of clinical investigation.

PTEN Loss is Associated with Upgrading of Prostate Cancer from Biopsy to Radical Prostatectomy

J. Hicks, E. Platz, A. D. De Marzo, 2014, Modern Pathology.

Biobanking of derivatives from radical retropubic and robot‐assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network

B. Trock, A. D. De Marzo, J. Melamed, 2014, The Prostate.

Biobankingof Derivatives From Radical Retropubic and Robot-AssistedLaparoscopicProstatectomyTissuesas PartoftheProstateCancerBiorepositoryNetwork

B. Trock, A. Marzo, J. Melamed, 2014 .

An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy

J. Hicks, A. D. De Marzo, H. Fedor, 2012, Cancer.

The Prostate 69 : 214 ^ 218 ( 2009 ) Genome-Wide ExpressionAnalysis of Recently ProcessedFormalin-FixedParaffinEmbeddedHuman ProstateTissues

W. Isaacs, Jun Luo, T. Dunn, 2008 .

PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for Active Surveillance

B. Trock, W. Samson, A. D. De Marzo, 2016, Modern Pathology.

Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

J. Cameron, L. Wood, R. Hruban, 2017, Annals of surgery.

Androgen receptor splice variant, AR-V7, and resistance to enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC).

Hao Wang, W. Isaacs, Jun Luo, 2014 .

Association of PTEN protein loss with upgrading of prostate cancer from biopsy to radical prostatectomy.

J. Hicks, E. Platz, Misop Han, 2014 .

MP53-17 CLINICAL VALIDATION OF THE 2005 ISUP GLEASON GRADING SYSTEM IN A COHORT OF INTERMEDIATE AND HIGH RISK MEN UNDERGOING RADICAL PROSTATECTOMY

B. Trock, A. Partin, Misop Han, 2015 .

POD-02.10: Individual and Cumulative Effect of Prostate Cancer Risk-associated Variants on Clinicopathologic Variables in 5,895 Prostate Cancer Patients

Jianfeng Xu, S. Zheng, Jishan Sun, 2009 .

Risk-AssociatedVariants onClinicopathologic Variables in 5 , 895 ProstateCancer Patients

B. Trock, Jianfeng Xu, Jielin Sun, 2009 .